1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Metastase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drings, P; Edler, L; Fiebig, HH; Gatzemeier, U; Hinke, A; Rieche, K; Tessen, HW | 1 |
Balslev, I; Ernst, P; Mouridsen, HT | 1 |
1 trial(s) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Metastase
Article | Year |
---|---|
Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Follow-Up Studies; Germany, West; Humans; Lung Neoplasms; Multicenter Studies as Topic; Neoplasm Metastasis; Nitrosourea Compounds; Survival Rate; Taurine | 1990 |
1 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Metastase
Article | Year |
---|---|
Second-line chemotherapy with tauromustine in metastatic breast cancer in postmenopausal women: a phase II study.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Taurine | 1987 |